Abstract:
:Although there are many models which are used to calculate the health benefits (and thus the cost-effectiveness) of vaccination programmes, they can be divided into two groups: those which assume a constant force of infection, that is a constant per-susceptible rate of infection; and those which assume that the force of infection (at time t) is a function of the number of infectious individuals in the population at that time (dynamic models). In constant force of infection models the per-susceptible rate of infection is not altered, whereas in dynamic models mass immunization results in fewer infectious individuals in the community and thus a lower force of infection acting on those who were not immunized. We take an example of each of these types of model, examine their underlying assumptions and compare their predictions of the cost-effectiveness of a mass immunization programme against a hypothetical close contact infection, such as measles. We show that if cases of infection are the outcome of interest then the constant force of infection model will always underestimate the cost-effectiveness of the immunization programme except at the extremes when no one or everyone is immunized. However, unlike the constant force of infection model, the dynamic model predicts an increase in the average age at infection after immunization which could impact on the estimate of the cost-effectiveness of the programme if the risk of developing serious disease is a function of the age at infection (as, for instance, is the case for congenital rubella syndrome). Taking cases of infection as the outcome measure and using the dynamic model, the undiscounted cost-effectiveness ratio will tend to decline over time and approach a constant value, as the system moves from pre- to post-immunization equilibrium. We go on to show how the cost-effectiveness of a fixed-term immunization programme might change over time, and discuss why, under most circumstances, decision makers should not assume that elimination (permitting termination of mass immunization) will occur.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Edmunds WJ,Medley GF,Nokes DJdoi
10.1002/(sici)1097-0258(19991215)18:23<3263::aid-ssubject
Has Abstractpub_date
1999-12-15 00:00:00pages
3263-82issue
23eissn
0277-6715issn
1097-0258pii
10.1002/(SICI)1097-0258(19991215)18:23<3263::AID-Sjournal_volume
18pub_type
杂志文章abstract::Although radical changes in drug regulation are rare (e.g., the Federal Food, Drug and Cosmetic Act of 1938 and the 1962 amendment to the Act creating an effectiveness requirement), regulations and guidance do evolve significantly in the face of new problems and accumulating experience. Recent changes have been driven...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1298
更新日期:2002-10-15 00:00:00
abstract::Randomized clinical trial designs commonly include one or more planned interim analyses. At these times an external monitoring committee reviews the accumulated data and determines whether it is scientifically and ethically appropriate for the study to continue. With failure-time endpoints, it is common to schedule an...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.843
更新日期:2001-07-30 00:00:00
abstract::We discuss a sample size calculation for a pair-matched case-control study to test for interaction between a specific exposure and a second risk factor. The second risk factor could be either binary or continuous. An algorithm for the calculation of sample size is suggested which is based on a logistic regression mode...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(20000415)19:7<923::aid-sim
更新日期:2000-04-15 00:00:00
abstract::Risk prediction procedures can be quite useful for the patient's treatment selection, prevention strategy, or disease management in evidence-based medicine. Often, potentially important new predictors are available in addition to the conventional markers. The question is how to quantify the improvement from the new ma...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5647
更新日期:2013-06-30 00:00:00
abstract::In the presence of confounding, the consistency assumption required for identification of causal effects may be violated due to misclassification of the outcome variable. We introduce an inverse probability weighted approach to rebalance covariates across treatment groups while mitigating the influence of differential...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7522
更新日期:2018-02-10 00:00:00
abstract::Members of a cohort of workers in chemical industry (the so-called Boehringer cohort) exposed to 2, 3, 7, 8-tetrachlorodibenzo-para-dioxin (TCDD) from 1950 to 1984 were subject in the years 1985-1986 and 1992-1994 to an extensive biomonitoring programme on the TCDD levels of the individual workers. For establishing a ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3074
更新日期:2008-05-30 00:00:00
abstract::In the study of multiple failure times for the same subjects, for example, recurrent infections for patients with a given disease, there are often subject effects, that is, subjects have different risks that cannot be explained by known covariates. Standard methods, which ignore subject effects, lead to overestimation...
journal_title:Statistics in medicine
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1002/(sici)1097-0258(19980615)17:11<1201::aid-s
更新日期:1998-06-15 00:00:00
abstract::In the pharmaceutical industry, some tests for quality assurance before, during and after the manufacture of a drug product involve a two-stage sampling technique. We propose statistical testing procedures in a two-stage sampling problem with large within-class sample sizes. We also derive a two-stage sampling plan by...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780122104
更新日期:1993-11-15 00:00:00
abstract::Residuals in normal regression are used to assess a model's goodness-of-fit (GOF) and discover directions for improving the model. However, there is a lack of residuals with a characterized reference distribution for censored regression. In this article, we propose to diagnose censored regression with normalized rando...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8852
更新日期:2020-12-13 00:00:00
abstract::Although prostate cancer and benign prostatic hyperplasia are major health problems in U.S. men, little is known about the early stages of the natural history of prostate disease. A molecular biomarker called prostate specific antigen (PSA), together with a unique longitudinal bank of frozen serum, now allows a histor...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780130520
更新日期:1994-03-15 00:00:00
abstract::Prevalence data provided by cancer registries are generally biased, since the patients that were diagnosed before the starting of the registry's activity cannot be included in the statistics. The relevance of this incompleteness bias is estimated in this paper. Incidence and relative survival are modelled as parametri...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19970228)16:4<425::aid-sim
更新日期:1997-02-28 00:00:00
abstract::We propose a joint model to analyze the structure and intensity of the association between longitudinal measurements of an ordinal marker and time to a relevant event. The longitudinal process is defined in terms of a proportional-odds cumulative logit model. Time-to-event is modeled through a left-truncated proportio...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7065
更新日期:2016-12-10 00:00:00
abstract::A problem occurring in chronic disease modeling is the estimation of transition probabilities of moving from one state of a categorical risk factor to another. Transitions could be obtained from a cohort study, but often such data may not be available. However, under the assumption that transitions remain stable over ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4423
更新日期:2012-03-15 00:00:00
abstract::Diagnostic problems in medicine are sometimes polytomous, meaning that the outcome has more than two distinct categories. For example, ovarian tumors can be benign, borderline, primary invasive, or metastatic. Extending the main measure of binary discrimination, the c-statistic or area under the ROC curve, to nominal ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5321
更新日期:2012-10-15 00:00:00
abstract::We develop reinforcement learning trials for discovering individualized treatment regimens for life-threatening diseases such as cancer. A temporal-difference learning method called Q-learning is utilized that involves learning an optimal policy from a single training set of finite longitudinal patient trajectories. A...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3720
更新日期:2009-11-20 00:00:00
abstract::Modelling disease clustering over space and time can be helpful in providing indications of possible exposures and planning corresponding public health practices. Though a considerable number of studies focus on modelling spatio-temporal patterns of disease, most of them do not directly model a spatio-temporal cluster...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2424
更新日期:2006-03-15 00:00:00
abstract::Methodology for the meta-analysis of individual patient data with survival end-points is proposed. Motivated by questions about the reliance on hazard ratios as summary measures of treatment effects, a parametric approach is considered and percentile ratios are introduced as an alternative to hazard ratios. The genera...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4086
更新日期:2010-12-20 00:00:00
abstract::Cross-sectional designs are often used to monitor the proportion of infections and other post-surgical complications acquired in hospitals. However, conventional methods for estimating incidence proportions when applied to cross-sectional data may provide estimators that are highly biased, as cross-sectional designs t...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5608
更新日期:2013-06-30 00:00:00
abstract::The need for resource-intensive laboratory assays to assess exposures in many epidemiologic studies provides ample motivation to consider study designs that incorporate pooled samples. In this paper, we consider the case in which specimens are combined for the purpose of determining the presence or absence of a pool-w...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4426
更新日期:2012-09-28 00:00:00
abstract::Comparative effectiveness research represents the kind of research that arguably more directly affects clinical practice and policy. It includes observational studies, clinical trials, and systematic syntheses of existing literature. In this commentary, I argue for the ongoing and critical role of randomization in com...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5400
更新日期:2012-11-10 00:00:00
abstract::When designing a study to develop a new prediction model with binary or time-to-event outcomes, researchers should ensure their sample size is adequate in terms of the number of participants (n) and outcome events (E) relative to the number of predictor parameters (p) considered for inclusion. We propose that the mini...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7992
更新日期:2019-03-30 00:00:00
abstract::In designed longitudinal studies, information from the same set of subjects are collected repeatedly over time. The longitudinal measurements are often subject to missing data which impose an analytic challenge. We propose a functional multiple imputation approach modeling longitudinal response profiles as smooth curv...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4201
更新日期:2011-05-10 00:00:00
abstract::Bioequivalence or interaction trials are commonly studied in crossover design and can be analysed by nonlinear mixed effects models as an alternative to noncompartmental approach. We propose an extension of the population Fisher information matrix in nonlinear mixed effects models to design crossover pharmacokinetic t...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4390
更新日期:2012-05-20 00:00:00
abstract::Bayesian methods are proposed for analysing matched case-control studies in which a binary exposure variable is sometimes measured with error, but whose correct values have been validated for a random sample of the matched case-control sets. Three models are considered. Model 1 makes few assumptions other than randomn...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2000
更新日期:2005-02-15 00:00:00
abstract::This paper examines several methods for deriving standardized morbidity ratios (SMR) and attributable fraction (attributable risk percentage) estimates. We show that some of the proposed methods will, in general, produce biased estimators, although the low variance of certain estimators sometimes compensates for their...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780030206
更新日期:1984-04-01 00:00:00
abstract::In studies with survival or time-to-event outcomes, a competing risk is an event whose occurrence precludes the occurrence of the primary event of interest. Specialized statistical methods must be used to analyze survival data in the presence of competing risks. We conducted a review of randomized controlled trials wi...
journal_title:Statistics in medicine
pub_type: 杂志文章,评审
doi:10.1002/sim.7215
更新日期:2017-04-15 00:00:00
abstract::Identification of the latency period for the effect of a time-varying exposure is key when assessing many environmental, nutritional, and behavioral risk factors. A pre-specified exposure metric involving an unknown latency parameter is often used in the statistical model for the exposure-disease relationship. Likelih...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8038
更新日期:2019-03-30 00:00:00
abstract::Various R(2) statistics have been proposed for logistic regression to quantify the extent to which the binary response can be predicted by a given logistic regression model and covariates. We study the asymptotic properties of three popular variance-based R(2) statistics. We find that two variance-based R(2) statistic...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2300
更新日期:2006-04-30 00:00:00
abstract::For the meta-analysis of controlled clinical trials or epidemiological studies, in which the responses are at least approximately normally distributed, a refined test for the hypothesis of no overall treatment effect is proposed. The test statistic is based on a direct estimation function for the variance of the overa...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.791
更新日期:2001-06-30 00:00:00
abstract::Many reactions in enzymology are governed by the Michaelis-Menten equation. Characterising these reactions requires the estimation of the parameters K(M) and V(max) which determine the Michaelis-Menten equation and this is done by observing rates of reactions at a set of substrate concentrations. The choice of substra...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1612
更新日期:2004-02-15 00:00:00